Journal ArticleCurr Treat Options Oncol · December 24, 2025
Improved survival in pediatric oncology has highlighted the growing burden of cancer treatment-related cardiotoxicity among survivors of childhood cancers. While the cardiotoxicity of anthracyclines and chest radiation are well documented as major contribu ...
Full textLink to itemCite
Journal ArticlePediatr Cardiol · December 2025
Patients with a single ventricle heart who had Fontan palliation (S/P Fontan) are at increased risk for acquired morbidity. Insulin resistance (IR) is a predictor of cardiac morbidity and mortality. A single-center, cross-sectional study using S/P Fontan a ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · October 2025
OBJECTIVE: Orthotopic heart transplant is the definitive option for pediatric patients with end-stage heart failure. Unfortunately, the greatest contributor to waitlist mortality has been a shortage of available hearts for transplant. Donation after circul ...
Full textLink to itemCite
Journal ArticleJAMA · September 23, 2025
IMPORTANCE: Partial heart transplant, or living valve replacement, has the potential to advance surgical management of irreparable valvular disease by providing a viable option with capacity for growth. OBJECTIVES: To describe the early experience and asse ...
Full textOpen AccessLink to itemCite
Journal ArticleTransplant Proc · October 2023
BACKGROUND: Infections have been associated with rejection episodes in solid organ transplant recipients. We report an association between COVID-19 infection and heart transplant (HT) rejection. CASE DESCRIPTION: The patient was 14 years old and 6.5 years ...
Full textLink to itemCite
Journal ArticleDrug Metab Dispos · January 2013
Studies in microsomal and reconstituted systems have shown that the presence of one cytochrome P450 isoform can significantly influence the catalytic activity of another isoform. In this study, we assessed whether CYP2E1 could influence the catalytic activ ...
Full textLink to itemCite
Journal ArticleBiochemistry · May 17, 2011
Cytochrome P450 (CYP or P450)-mediated drug metabolism requires the interaction of P450s with their redox partner, cytochrome P450 reductase (CPR). In this work, we have investigated the role of P450 hydrophobic residues in complex formation with CPR and u ...
Full textLink to itemCite